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ABSTRACT
Background: Although the World Health Organization (WHO) classifies Turkey as a 
country with a moderate-high prevalence of hepatitis B virus (HBV) infection, there is 
little data on HBV transmission in this country.
Objectives: To identify risk factors for HBV infection, we performed a retrospective case-
control study between January 2007 and December 2009.
Patients and Methods: Acute HBV patients and population controls were selected, and 
data from these groups were analyzed by logistic regression. method. 
Results: The study included 129 patients with acute HBV infection and 219 controls. He-
modialysis (OR:8.2, 95% CI: 4.17-16.61, p < 0.05), having an HBsAg (+) spouse (OR: 4.3, 
95% CI:2.17-8.53, p < 0.05), living with an HBsAg (+) parent(s) (OR: 3.25, 95% CI:1.73-6.12, 
p < 0.05), and being male (OR: 1.34, 95% CI: 0.82-2.21, p < 0.05) were independent risk 
factors that were potentially associated with HBV infection. More than one-third of 
female patients had a significantly higher risk (34.5% vs. 13.5%, p < 0.05) of acquiring 
HBV from their sexual partners. Hemodialysis was the most frequent risk factor (46.9% 
vs. 20%, x² = 10.45, p < 0.05) for patients aged over 31 years, and living with HBsAg (+) 
parents was a significantly higher risk factor (28.8% vs. 10.2%, x² = 6.15, p < 0.05) that is 
more likely to lead to HBVin patients aged under 30 years. 
Conclusions: This study suggests that persons in Turkey who undergo hemodialysis 
are at high risk for acquiring HBV. Having an HBsAg (+) spouse (sexual transmission) 
or living with HBsAg (+) parents (household transmission) are significant risk factors 
for HBV transmission. Vaccination appears to be better preventive method against the 
spread of HBV.
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Background
Hepatitis B virus (HBV) is a leading cause of liver dis-
ease, affecting many populations throughout the world. 
Approximately  one-third  of  living  persons  have  been 
infected with HBV at one point in their lives, and 350 
million of them have become chronic HBV patients or 
carriers. More than 1 million people die each year due 
to HBV-related diseases, such as chronic active hepati-
tis, cirrhosis, and hepatocellular carcinoma (1, 2). HBV 
is transmitted through several routes: drug use-related 
injections; exposure to HBV-positive blood or other body 
fluids;  heterosexual  or  male  homosexual  sexual  activ-
ity; from mother to infant (or vertically); and between 
children in a household (or horizontally) (3). Identifica-
tion of transmission routes can help improve preventive 
measures.
In Turkey, safe and effective vaccines have been available 
since the early 1990s, and a nationwide HBV vaccination 
program  has  been  implemented  since  1998.  However, 
there are 4-4.6 million people with chronic HBV infection 
in Turkey (4). The Health Ministry has reported that a to-
tal of 6600 new HBV infections have been diagnosed, 4 
of whom died due to acute liver dysfunction in 2006 (5). 
Although Turkey is a country with an intermediate-high 
prevalence of HBV infection (6), the means by which HBV 
is spread in Turkey must be clarified. 
Objectives
In this study, we conducted a population-based, case-
controlled study to determine the potential risk factors 
for HBV transmission in the Turkish population. 
Patients and Methods
Study Design and Population
This study was conducted between January 2007 and 
December 2009 in Malatya City. This city is located in mid-
eastern Anatolia and has an estimated urban population 
of 555,000 and an estimated rural population of 15,000. 
The study was performed in the Public Health Office with 
the participation of two state hospitals. To identify risk 
factors for HBV acquisition, we conducted a case-control 
study. The Public Health Department generated the case 
and  control  groups.  All  patients  who  were  diagnosed 
with acute HBV infection within the study periods were 
eligible for inclusion. The case definition of acute HBV 
infection  was  made,  with  some  modifications,  using 
criteria per the Council of State and Territorial Epidemi-
ologists (CSTE) (7). Control groups consisted of healthy 
residents who met the demographic characteristics of 
the study population and who could be documented as 
negative for any current and/or previous HBV infection. 
Chronic HBV patients, vaccinated persons, healthy carri-
ers, and formerly infected individuals were not included. 
Patients and controls were requested to provide written 
informed consent. All adult patients and controls were 
volunteers. Nonadult patients were included only with 
their parents’ permission. 
Data collection
A wide range of possible risk factors were investigated 
with regard to HBV transmission (8). All subjects were 
questioned  about  dental  visits,  barber  visits,  blood 
transfusions, circumcision, hospitalizations, having an 
HBsAg-positive spouse (wife, husband, or regular sexual 
partner),  commercial  sex  use,  commercial  sex  work, 
piercings, tattoos, intravenous drug use, narcotic addic-
tion, homosexual contact, living with an HBsAg-positive 
parent, and working as a health care worker (HCW).
In interviews with the patients and controls, a standard 
questionnaire form that included these data was com-
pleted. The questionnaire had two formats, depending 
on the age of the respondent. One form was designated 
for nonadult patients (aged ≤ 16 years), who consequent-
ly were not queried on sexual activity. Respondents were 
asked  about  their  contact  with  potential  risk  factors 
within the last 6 weeks and within the last 6 months, 
which reflects the incubation period for HBV infection. 
The  demographics  of  the  cases  and  control  patients, 
such as age, gender, marital status, educational level, and 
occupation, were recorded. The data nonadult patients 
were obtained with their parents’ guidance.
Regarding  the  frequency  of  procedures,  dental  visits 
were coded into three categories: no dental visits were 
coded as negative, having made only one visit was coded 
as 1, and having made two or more visits within the in-
cubation period was coded as 2. Visits for noninvasive 
procedures were excluded. Visits to the barber (or beauty 
salon) also included shaves (for males), manicures, pedi-
cures,  epilating  (electrolysis),  peeling,  skin  care,  and 
acupuncture. Barber visits were also scored from 0 to ≥ 
3, according to the frequency of the procedure in the pre-
vious 6 weeks and 6 months. Piercings included persons 
who experienced an insertion of any external accessory, 
such as earrings or ornaments, into the skin or mucosal 
tissue.
Laboratory analysis
Serum samples were analyzed for HBV markers using 
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(US),  in  the  clinical  microbiology  laboratories  at  both 
participating  hospitals.  HBsAg,  anti-HBs,  anti-HBc-IgG 
and IgM, HBeAg, and anti-HBe were measured for each 
patient. Biochemical parameters, such as AST, ALT, and 
ALP, were also measured using the Abboth System (US) 
and Beckman-Coulter (US) systems simultaneously.
Statistical analysis
We used the Statistical Package for Social Sciences (SPSS 
Inc., Chicago, IL, USA), version 11.0 for Windows, to per-
form the statistical analyses. The data were initially tested 
for normal distribution by Kolmogorov-Smirnov test and 
found to be normal (p > 0.05). We used the multiple lo-
gistic regression and chi-square tests for statistical analy-
sis. P < 0.05 was accepted as statistically significant.
Results
Patients and controls
During the study period, a total of 155 patients were di-
agnosed with acute HBV infection, 138 of whom were will-
ing to participate in the study. The remaining 17 patients 
were  excluded  (12  refused  to  be  included,  and  5  were 
unavailable for interview). In addition, 9 patients were 
excluded due to incomplete data, as they failed to com-
plete the questionnaire forms. The mean age of the 129 
participating patients was 30.4 ± 17.5 years (ranging from 
7 to 80 years). The study group was predominantly male 
(57.4%/42.6%). The age and sex of the patients are shown 
in Figure 1. Thirty-nine cases were hemodialysis patients, 
and the remaining 90 patients were healthy individuals.
Nearly  half  of  the  patients  (48.1%)  earned  over  1600 
Turkish Liras (1200 USD) per month per family, which is 
the average income for a Turkish individual. Nineteen 
percent of the patients declared that they were university 
graduates, and 56.6% said that they graduated from high 
school.  Seventy-one  percent  were  residents  of  Malatya 
City,  and  27%  came  from  the  surrounding  rural  areas. 
Of the 410 individuals who were evaluated, 219 were eli-
gible for inclusion as control subjects. The mean age of 
the controls was 30.8 ± 17.5 years (ranging from 7 to 80 
years), and the male/female ratio was 66.2%/33.8%. Both 
groups shared similar socioeconomic and demographic 
characteristics.
Risk factors
Thirty-nine patients reported hemodialysis, 35 report-
ed over two dental visits, 25 reported over three barber 
visits, 29 reported having an HBV-positive spouse, 28 re-
ported living with an HBsAg-positive parent, 11 reported 
hospital stays, 3 reported blood transfusions (all were 
multiple transfusions), 4 reported piercings (3 were ear-
rings, 1 was a nasal piercing), 2 reported circumcisions, 
2 reported multiple sex partners, and 1 reported com-
mercial sex use. Nine (6.9%) patients did not select any 
potential risk factor. No patient declared homosexual ac-
tivity, having tattoos, narcotic use, intravenous drug use, 
commercial sex work, or an HCW job. By logistic regres-
sion analysis of the two groups, hemodialysis, having an 
HBV-positive spouse, living with HBsAg-positive parent, 
and male gender were found to be independent risk fac-
tors for acquisition of HBV. Table 1 shows the results of the 
multivariate analysis for HBV infection.
When the identified risk factors were analyzed, females 
had  a  significantly  higher  risk  for  acquiring  the  virus 
from their positive spouse. However, males experienced 
no such pattern. Living with an HBsAg-positive parent 
and undergoing hemodialysis were significant risk fac-
tors for patients aged under 30 and over 31 years, respec-
tively. Table 2 and Table 3 show the statistical analysis of 
the risk factors, based on patient age and gender.
Discussion
The public health burden of HBV infection is due al-
most entirely to its long-term effects on liver function. In 
addition to health problems, these diseases cause broad-
er social and economic problems. More than $1 billion is 
spent  annually  for  hepatitis  B-related  hospitalizations 
(9). Although it is very difficult to measure, the total cost 
of HBV might be several magnitudes greater.
HBV is acquired by percutaneous and mucosal exposure 
to the body fluids of an infected person. However, there 
is considerable variation in transmission mode between 
Factors Patients 
No. (%)
Controls 
No. (%)
Odds ratio 95% CI p-value
Gender 
Female 
Male
55 (42.6)
74 (57.4)
74 (33.8)
145 (66.2)
1.00
1.34
0.82-2.21 0.245
Hemodialysis
Positive
Negative
39 (30.2)
90 (69.8)
14 (6.4)
205 (93.6)
8.32
1.00
4.17-16.61 < 0.001
HBsAg (+) Spouse
Positive 
Negative
29 (22.5)
100 (77.5)
18 (8.2)
201 (91.8)
4.30
1.00
2.17-8.53 < 0.001
HBsAg (+) Parents
Positive
Negative
28 (21.7)
101 (78.3)
26 (11.9)
193 (88.1)
3.25
1.00
1.73-6.12 < 0.001
Table 1. Multivariate analysis of factors potentially associated with acute HBV infectionHepat Mon. 2011;11(4):263-268
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geographic areas and populations (2). In endemic coun-
tries  (≥  8%  chronic  HBV  patients),  most  infections  are 
acquired prenatally or during childhood via close house-
hold contacts (10). Alternatively, in countries where the 
prevalence of HBV is low (≤ 2 chronic HBV patients), most 
infections are acquired in adult life (11).
HBV positivity is associated with a history of multiple 
sex partners, male homosexual activity, and illicit drug 
use (IDU and/or intranasal cocaine use) in western coun-
tries (12, 13). Correspondingly, in addition to the predomi-
nance of sexual transmission in adults, Hahné et al. (14) 
reported that having parent(s) born in a highly endemic 
country is a significant risk factor in the acquisition of 
HBV among children in the Netherlands. Hutin and col-
leagues  (15)  emphasized  nosocomial  transmission,  re-
porting that injections in health care settings are a major 
source of HBV transmission in Moldova, a result of the 
widespread  reuse  of  inadequately  sterilized  single-use 
syringes. 
In this study, we determined that hemodialysis, mar-
riage to an HBsAg-positive person, and living with HBsAg-
positive parent(s) were independent risk factors for HBV 
transmission in a Turkish population (Table 1). Although 
the frequency of other proposed risk factors, such as den-
tal visits, barber visits, blood transfusions, and surgery, 
was higher in the patient group, no significant differ-
ence was observed in the controls. No patient reported 
homosexual activity, tattoos, narcotic use, intravenous 
drug use, or commercial sex work, suggesting that di-
rect transmission through these routes is infrequent in 
Turkey.  Nonetheless,  these  activities  are  predominant 
behaviors that are associated with HBV patients in many 
western countries. This difference might be a reflection 
of the sociocultural characteristics of the Turkish popu-
lation. Nevertheless, it is possible that some of our sub-
jects might have been reluctant to declare such activities 
due to social concerns.
More than half of our patients were young adults (age 
range, 15-40 years) (Figure 1). This result may be due to the 
rising incidence of risk factors toward the end of adoles-
Table 2. Distribution of the risk factors according to  gender 
Risk Factors
Gender
x² p-value Male 
No. (%)
Female 
No. (%)
HBsAg (+) Spouse  10 (13.5) 19 (34.5) 8.00 < 0.001
Hemodialysis (+) 24 (32.5) 15 (27.3) 0.39 0.52
HBsAg (+) Parents  20 (27.0) 8 (14.5) 2.89 0.09
Risk Factors
Age (years)
x² p-value ≤ 30 
No. (%)
≥ 31 
No. (%)
HBsA (+) Spouse 15/18.8 14/28.6 1.68 0.20
Hemodialysis (+) 16/20.0 23/46.9 10.45 < 0.001
HBsAg (+) Parents 23/28.8 5/10.2 6.15 0.01
Table 3. Distribution of the risk factors according to age 
cence. In contrast, we noted a decrease in the number of 
patients aged in their 40s and a slight increase in those 
over 50  years (accounted for primarily by hemodialysis 
patients) (Figure 1). When independent risk factors were 
analyzed with respect to age and gender, living with HB-
sAg-positive parent(s) was a significantly predominant 
risk factor among patients aged under 30 years. We be-
lieved that this was most likely due to household trans-
mission (Table 3). Furthermore, hemodialysis was a signif-
icant risk factor for patients aged over 31 years (Table 3), 
possibly due to the increasing incidence of chronic renal 
diseases with age in our population.
In 2003, The Health Ministry reported that the propor-
tion of patients aged 0-9 years accounted for 6% of acute 
HBV patients (16). However, we found few cases among 
children aged under 10 years (n = 5, 3.8%) throughout the 
study period. We believed that this is a result attributed 
to  the  national  vaccination  program.  Parents  of  these 
pediatric patients reported that they could not continue 
the vaccination program after the initial dose. In addi-
tion, no protective antibody titer was detected in these 
five children. Not surprisingly, in 2006, official statistics 
suggested that noncompliance with HBV-3 vaccination 
at age 0 ranged from 11% to 20% across the country (5).
We found that hemodialysis was the most significant 
risk factor for HBV transmission in our study. However, 
hemodialysis patients in Turkey are conventionally vacci-
nated against HBV. Additionally, HBV-positive-labeled de-
vices are not used for negative patients in large centers. 
The poor condition of facilities with dialysis units (par-
ticularly in private health care centers), the few devices 
that are available to large populations, and the low ad-
herence to infection control measures (i.e., inadequate 
disinfection of devices by patients) might be some of the 
major reasons for the significant device-associated HBV 
transmission in Turkey.
Furthermore,  a  dialysis  patient  undergoes  several 
rounds of dialysis until vaccinations are able to provide 
a protective antibody titer. Although it is rare, occult HBV 
infections among patients with chronic renal failure risk 
can  contaminating  HBV-negative-labeled  devices  (17). 
When other risk-bearing activities, such as blood trans-
fusions  and  surgery,  were  pooled  with  hemodialysis, 
nosocomial  transmission  of  the  pathogen  was  identi-
fied as one of the most significant transmission modes 
in  the  studied  population  our  population.  Therefore, 
Figure 1.  Age and sex distribution of patients with acute HBV infection
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our results suggest that nosocomial hygiene and infec-
tion control measures must be improved to reduce HBV 
transmission in Turkey. 
A total of 29 patients reported having an HBsAg-positive 
sexual partner. Our statistical analysis revealed a signifi-
cant predominance of this risk factor for women com-
pared with male patients (13.5% vs. 34.5, p < 0.05) (Table 
2). When hemodialysis patients (n = 15) and sexually inac-
tive patients (n = 9) were excluded from the female cases, 
61.2% of the women were likely to have acquired the virus 
from their positive partners. In fact, a number of laws 
that  are  designed  to  prevent  the  spread  of  communi-
cable diseases in Turkey have been written over the past 
10 years. For example, couples are asked undergo a num-
ber of blood tests (e.g., HBsAg, anti-HIV-I/II, VDRL, and 
anti-HCV) when they apply to be married. Anyone who 
is found to be HBsAg-positive in such tests is directed to 
an infectious diseases resident to learn about the disease 
and infection control measures (vaccinations, condom 
use, etc).
However, these activities do not provide adequate pre-
vention against HBV transmission. For example, although 
a spouse is vaccinated, couples can marry before protec-
tive immunity is established. In addition, in Turkey, due 
to its large traditional population and the strict male 
dominance of social life, women often face considerable 
obstacles in following a regular vaccination program.
Interestingly,  two  young  female  patients  whose  hus-
bands  were  HBsAg-positive  reported  that  they  had  re-
fused to be vaccinated because they were worried that 
the vaccinations could cause them to lose their repro-
ductive capacities before getting married. A low educa-
tional level and superstitious populations might be the 
chief reasons for such problems. Additionally, many fe-
male patients reported that their HBV-positive husbands 
had simply chosen not to use condom. We believe that 
such  characteristics  of  our  cultural  structure  increase 
the risk of HBV transmission from males to females in 
our country.
In  Turkey,  Kose  et  al.  (18)  recently  reported  that  HBV 
transmission in 958 chronic HBV patients was associat-
ed with having an HBV (+) family member (80.6%), being 
HCW (9.2%), hemodialysis (2.8%), and being an oncology 
patient (2.1%). However, we selected only acute HBV pa-
tients in this study. We believe that our method is likely 
to provide more accurate and current data, in contrast to 
chronic HBV patients with long histories.
As there has been no successful treatment option for 
chronic patients, the principal strategy for controlling 
HBV infection is vaccination. The World Health Organi-
zation has recommended routine HBV vaccinations for 
newborns since 1992. In Turkey, recombinant HBV vac-
cine is available at primary care centers free of charge 
to any applicant, and a nationwide vaccination program 
has been in existence for the past 11 years. This program 
entails the immunzation of all children at birth, vaccina-
tions and immunoglobulin injections to the newborn if 
the mother is HBsAg-positive, and routine immunization 
of high-risk people (e.g., HCWs).
In the United States, between 1990 and 2002, the inci-
dence of acute HBV infection declined from 8.5 to 2.8 (per 
100,000) in the general population after the implemen-
tation of a routine HBV vaccination program. However, 
the  most  significant  decline  in  acute  hepatitis  B  inci-
dence occurred among persons aged 0-19 years, from 3.0 
in 1990 to 0.3 in 2002 (19). In contrast, the Turkish Health 
Ministry reported that the incidence of the disease rose 
unexpectedly  from  4.55  to  10.05  (per  100,000  of  the 
population) between 1990 and 2006 (5), the reasons for 
which have not been identified. We believe that despite 
the vaccination program, the increased sophistication of 
medical recording and reporting systems and the rising 
standards for assessments have merely clarified the ac-
tual status of HBV in the country.
The World Health Organization categorizes HBV infec-
tion as an occupational disease for certain groups. For 13 
years, the Health Ministry has regulated HCWs for HBV 
vaccination  and  have  recommended  that  they  ensure 
that  protective  immunity  has  been  provided.  In  this 
study, we did not identify any HCW with an acute HBV 
infection. We believe that the highest compliance rates 
of HCWs with HBV vaccination programs are most likely 
due to their exposure to recurrent informational activi-
ties about the disease.
The results of this study suggest that transmission of 
HBV takes place predominantly via nosocomial routes 
in older patients and by sexual and household routes in 
younger patients in Turkey. Such investigations are im-
portant for the identification of potential risk factors and 
the determination of high-risk groups and behaviours. 
Although the more than 10 years of the vaccination pro-
gram has led to a remarkable decrease in the incidence 
of  HBV  infection  among  children  and  certain  groups 
(such as HCWs), it is still not possible to claim that reli-
able protection has been achieved for the Turkish society. 
Education of the public about the disease may reduce so-
ciocultural resistance to preventive measures including 
vaccination  activities.  Providing  a  protective  antibody 
titer  in  the  early  years  of  life  may  protect  individuals 
against HBV acquisition, as will be determined soon.
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